Skip to main content

Atle Fund Management AB

13F filer · CIK 0001381843
Reported Jul 24, 2026
Net seller this quarter
13F portfolio value$372MU.S. long equity reported on 13F
Positions393 new · 3 closed
Net flow last quarter-$193MBuys minus sells
Top 10 positions weight48.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Jul 24, 202639 positions
LLYELI LILLY & Co$35.8M9.62%0.00%-24.9%Q4 2017
MRKMerck & Co., Inc.$24.3M6.55%0.01%+459.4%Q1 2016
JNJJohnson & Johnson$21.7M5.84%0.00%-7.5%Q1 2026
ABBVAbbVie Inc.$16.2M4.35%0.00%-40.5%Q4 2020
CVSCVS HEALTH Corp$15.1M4.07%0.01%+514.6%Q1 2021
TMOThermo Fisher Scientific Inc.$14M3.76%0.01%+21.2%Q4 2022
RVMDRevolution Medicines, Inc.$13.7M3.68%0.03%-88.2%Q4 2024
BIIBBiogen Inc.$13.6M3.65%0.04%Not reportedQ2 2017
NBIXNeurocrine Biosciences Inc$12.3M3.31%0.07%-18.7%Q4 2022
MIRMMirum Pharmaceuticals, Inc.$11.8M3.17%0.16%-48.5%Q1 2024
ALKSAlkermes plc.$11.2M3.01%0.13%-12.0%Q2 2024
IONSIonis Pharmaceuticals Inc$10.9M2.93%0.08%+392.0%Q4 2023
ONCBeOne Medicines Ltd.$10M2.70%0.00%-15.7%Q4 2024
ISRGIntuitive Surgical Inc$9.81M2.64%0.01%-65.2%Q1 2025
SYKStryker Corp$9.53M2.57%0.01%+12.9%Q4 2022
VRTXVertex Pharmaceuticals Inc / Ma$9.5M2.56%0.01%-16.8%Q1 2021
EWEdwards Lifesciences Corp$9.34M2.51%0.02%-3.1%Q4 2022
BBIOBridgeBio Pharma, Inc.$9.29M2.50%0.06%+12.0%Q4 2022
KRYSKrystal Biotech, Inc.$8.93M2.40%0.08%-36.1%Q4 2022
CORCencora, Inc.$8.81M2.37%0.02%+32.6%Q2 2016
NAMSNewAmsterdam Pharma Co N.V.$8.43M2.27%0.21%+162.5%Q1 2024
ABVXAbivax S.A.$7.75M2.09%0.07%+84.1%Q4 2025
INCYIncyte Corp$6.46M1.74%0.03%+12.1%Q4 2025
IRTCiRhythm Holdings, Inc.$6.44M1.73%0.16%+142.4%Q1 2025
BSXBoston Scientific Corp$6.25M1.68%0.01%+262.0%Q4 2022
INSMINSMED Inc$6.22M1.67%0.03%-40.1%Q4 2025
TNGXTango Therapeutics, Inc.$6.21M1.67%0.12%+563.7%Q1 2026
GILDGilead Sciences, Inc.$5.83M1.57%0.00%-3.8%Q2 2014
CAHCardinal Health Inc$5.61M1.51%0.01%-78.3%Q1 2014
ORKAOruka Therapeutics, Inc.$5.22M1.41%0.09%NewQ2 2026
SYRESpyre Therapeutics, Inc.$5.06M1.36%0.06%-9.1%Q1 2026
DXCMDexcom Inc$4.84M1.30%0.02%-87.7%Q4 2022
BCAXBicara Therapeutics Inc.$4.32M1.16%0.22%-87.6%Q1 2025
IDYAIDEAYA Biosciences, Inc.$3.52M0.95%0.10%+203.5%Q4 2025
CELCCelcuity Inc.$3.49M0.94%0.07%-76.4%Q3 2025
IRONDisc Medicine, Inc.$3.19M0.86%0.11%-59.3%Q2 2025
PYXSPyxis Oncology, Inc.$2.91M0.78%1.52%+390.5%Q4 2025
CMPXCompass Therapeutics, Inc.$2.3M0.62%0.58%+2406.7%Q4 2025
JBIOJade Biosciences, Inc.$1.97M0.53%0.14%NewQ2 2026
Q1 2026Reported May 11, 202639 positions
LLYELI LILLY & Co$26.8M8.67%0.00%+27.6%Q4 2017
MRKMerck & Co., Inc.$22.9M7.40%0.00%-82.7%Q1 2016
TMOThermo Fisher Scientific Inc.$14.4M4.67%0.01%-23.2%Q4 2022
ONCBeOne Medicines Ltd.$12.1M3.92%0.00%+3.2%Q4 2024
JNJJohnson & Johnson$11.9M3.86%0.00%NewQ1 2026
BBIOBridgeBio Pharma, Inc.$11.9M3.84%0.06%-21.2%Q4 2022
VRTXVertex Pharmaceuticals Inc / Ma$11.2M3.61%0.01%Not reportedQ1 2021
ABBVAbbVie Inc.$10.4M3.35%0.01%Not reportedQ4 2020
SYKStryker Corp$9.58M3.09%0.01%Not reportedQ4 2022
ISRGIntuitive Surgical Inc$9.44M3.05%0.02%+217.4%Q1 2025
IONSIonis Pharmaceuticals Inc$9.4M3.03%0.02%-69.8%Q4 2023
MIRMMirum Pharmaceuticals, Inc.$9.4M3.03%0.32%+118.3%Q1 2024
CVSCVS HEALTH Corp$9.27M2.99%0.00%-77.7%Q1 2021
RVMDRevolution Medicines, Inc.$9.08M2.93%0.31%+584.4%Q4 2024
BSXBoston Scientific Corp$8.84M2.86%0.00%-62.8%Q4 2022
AMGNAmgen Inc$8.72M2.81%0.00%Not reportedQ4 2023
EWEdwards Lifesciences Corp$8.27M2.67%0.02%Not reportedQ4 2022
ALKSAlkermes plc.$8.24M2.66%0.15%Not reportedQ2 2024
INCYIncyte Corp$7.97M2.57%0.03%-28.3%Q4 2025
NBIXNeurocrine Biosciences Inc$7.85M2.54%0.09%-5.4%Q4 2022
GILDGilead Sciences, Inc.$7.16M2.31%0.00%-5.6%Q2 2014
KRYSKrystal Biotech, Inc.$6.79M2.19%0.13%+11.0%Q4 2022
CORCencora, Inc.$6.6M2.13%0.01%-1.3%Q2 2016
IRTCiRhythm Holdings, Inc.$6.26M2.02%0.07%-40.6%Q1 2025
INSMINSMED Inc$5.96M1.92%0.05%+249.6%Q4 2025
NAMSNewAmsterdam Pharma Co N.V.$5.51M1.78%0.08%-51.9%Q1 2024
CELCCelcuity Inc.$5.14M1.66%0.29%+237.8%Q3 2025
ABVXAbivax S.A.$4.78M1.54%0.04%Not reportedQ4 2025
CAHCardinal Health Inc$4.77M1.54%0.05%+363.1%Q1 2014
IDYAIDEAYA Biosciences, Inc.$4.01M1.30%0.04%-68.1%Q4 2025
TNGXTango Therapeutics, Inc.$3.63M1.17%0.02%NewQ1 2026
SYRESpyre Therapeutics, Inc.$3.49M1.13%0.08%NewQ1 2026
IRONDisc Medicine, Inc.$3.19M1.03%0.28%+123.6%Q2 2025
CMPXCompass Therapeutics, Inc.$3.05M0.99%0.02%-92.8%Q4 2025
UNHUnitedhealth Group Inc$2.77M0.90%0.00%Not reportedQ4 2022
DXCMDexcom Inc$2.64M0.85%0.15%+1371.1%Q4 2022
BCAXBicara Therapeutics Inc.$2.32M0.75%1.78%+950.3%Q1 2025
SLNOSoleno Therapeutics Inc$2.21M0.71%0.17%+43.8%Q3 2024
PYXSPyxis Oncology, Inc.$1.62M0.52%0.31%-68.1%Q4 2025
Q4 2025Reported Feb 6, 202639 positions
LLYELI LILLY & Co$33.5M10.67%0.00%-16.4%Q4 2017
ABBVAbbVie Inc.$24.7M7.89%0.01%+17.5%Q4 2020
MRKMerck & Co., Inc.$20.6M6.57%0.01%+21.7%Q1 2016
TMOThermo Fisher Scientific Inc.$17.3M5.53%0.01%+10.2%Q4 2022
NBIXNeurocrine Biosciences Inc$13.4M4.29%0.09%-7.6%Q4 2022
ISRGIntuitive Surgical Inc$12.6M4.03%0.01%+13.3%Q1 2025
ONCBeOne Medicines Ltd.$12.3M3.92%0.00%+33.3%Q4 2024
BBIOBridgeBio Pharma, Inc.$10.8M3.45%0.07%-19.1%Q4 2022
VRTXVertex Pharmaceuticals Inc / Ma$10.4M3.32%0.01%+29.4%Q1 2021
BSXBoston Scientific Corp$10.4M3.31%0.01%+25.4%Q4 2022
SYKStryker Corp$9.43M3.01%0.01%+17.9%Q4 2022
CVSCVS HEALTH Corp$8.45M2.70%0.01%Not reportedQ1 2021
KRYSKrystal Biotech, Inc.$8.35M2.66%0.12%-19.8%Q4 2022
CORCencora, Inc.$8.03M2.56%0.01%-16.9%Q2 2016
IONSIonis Pharmaceuticals Inc$7.31M2.33%0.06%Not reportedQ4 2023
RVMDRevolution Medicines, Inc.$7.18M2.29%0.05%+5.7%Q4 2024
AMGNAmgen Inc$7.17M2.29%0.00%+58.7%Q4 2023
MIRMMirum Pharmaceuticals, Inc.$7.08M2.26%0.17%-4.2%Q1 2024
INCYIncyte Corp$7M2.23%0.04%NewQ4 2025
NAMSNewAmsterdam Pharma Co N.V.$6.91M2.21%0.17%+1.8%Q1 2024
ALKSAlkermes plc.$6.78M2.16%0.15%-4.1%Q2 2024
IRTCiRhythm Holdings, Inc.$6.67M2.13%0.12%+25.3%Q1 2025
GILDGilead Sciences, Inc.$6.23M1.99%0.00%-35.0%Q2 2014
UFPTUfp Technologies Inc$5.1M1.63%0.30%Not reportedQ2 2024
INSMINSMED Inc$4.85M1.55%0.01%NewQ4 2025
CAHCardinal Health Inc$4.82M1.54%0.01%-22.5%Q1 2014
ABVXAbivax S.A.$4.26M1.36%0.04%NewQ4 2025
CELCCelcuity Inc.$4.17M1.33%0.09%+12.6%Q3 2025
IRONDisc Medicine, Inc.$3.81M1.22%0.13%+5.0%Q2 2025
IDYAIDEAYA Biosciences, Inc.$3.37M1.07%0.11%NewQ4 2025
UNHUnitedhealth Group Inc$3.19M1.02%0.00%+6.6%Q4 2022
CMPXCompass Therapeutics, Inc.$3.14M1.00%0.33%NewQ4 2025
SLNOSoleno Therapeutics Inc$2.9M0.93%0.12%+4.3%Q3 2024
ACLXArcellx, Inc.$2.72M0.87%0.07%+62.1%Q4 2022
DXCMDexcom Inc$2.64M0.84%0.01%-21.9%Q4 2022
AUTLAutolus Therapeutics plc$2.33M0.74%0.44%Not reportedQ4 2023
BCAXBicara Therapeutics Inc.$1.87M0.60%0.20%-45.3%Q1 2025
CRBPCorbus Pharmaceuticals Holdings, Inc.$873K0.28%0.61%-38.9%Q1 2024
PYXSPyxis Oncology, Inc.$710K0.23%0.98%NewQ4 2025
Q3 2025Reported Nov 4, 202538 positions
LLYELI LILLY & Co$3.02M11.19%0.00%-3.8%Q4 2017
ABBVAbbVie Inc.$2.26M8.40%0.01%+6.0%Q4 2020
NBIXNeurocrine Biosciences Inc$1.53M5.67%0.10%+16.1%Q4 2022
MRKMerck & Co., Inc.$1.43M5.32%0.01%+15.6%Q1 2016
TMOThermo Fisher Scientific Inc.$1.4M5.18%0.01%+11.9%Q4 2022
ONCBeOne Medicines Ltd.$1.1M4.07%0.00%+24.4%Q4 2024
BBIOBridgeBio Pharma, Inc.$963K3.57%0.09%+5.6%Q4 2022
CORCencora, Inc.$949K3.52%0.01%-9.1%Q2 2016
ISRGIntuitive Surgical Inc$936K3.47%0.01%+6.2%Q1 2025
GILDGilead Sciences, Inc.$921K3.42%0.01%+6.8%Q2 2014
BSXBoston Scientific Corp$898K3.33%0.01%-31.3%Q4 2022
SYKStryker Corp$894K3.31%0.01%-17.1%Q4 2022
ALKSAlkermes plc.$805K2.99%0.15%+11.3%Q2 2024
KRYSKrystal Biotech, Inc.$791K2.93%0.15%+109.3%Q4 2022
VRTXVertex Pharmaceuticals Inc / Ma$739K2.74%0.01%-27.0%Q1 2021
MIRMMirum Pharmaceuticals, Inc.$729K2.70%0.18%-12.5%Q1 2024
NAMSNewAmsterdam Pharma Co N.V.$585K2.17%0.17%+23.2%Q1 2024
IRTCiRhythm Holdings, Inc.$548K2.03%0.09%+18.5%Q1 2025
EWEdwards Lifesciences Corp$542K2.01%0.01%+14.5%Q4 2022
CAHCardinal Health Inc$505K1.87%0.01%+13.1%Q1 2014
UFPTUfp Technologies Inc$487K1.81%0.30%+5.0%Q2 2024
MRUSMerus N.V.$480K1.78%0.06%-19.9%Q4 2022
SLNOSoleno Therapeutics Inc$432K1.60%0.11%+48.4%Q3 2024
RVMDRevolution Medicines, Inc.$423K1.57%0.05%+3.7%Q4 2024
AMGNAmgen Inc$414K1.53%0.00%-42.2%Q4 2023
DXCMDexcom Inc$363K1.35%0.01%Not reportedQ4 2022
BCAXBicara Therapeutics Inc.$342K1.27%0.37%+38.3%Q1 2025
IRONDisc Medicine, Inc.$321K1.19%0.13%+85.3%Q2 2025
UNHUnitedhealth Group Inc$298K1.10%0.00%Not reportedQ4 2022
HRMYHarmony Biosciences Holdings, Inc.$269K1.00%0.16%+6.7%Q3 2021
RNAMAvidity Biosciences, Inc.$240K0.89%0.04%NewQ3 2025
CRBPCorbus Pharmaceuticals Holdings, Inc.$236K0.87%1.40%Not reportedQ1 2024
ACLXArcellx, Inc.$224K0.83%0.04%Not reportedQ4 2022
SMMTSummit Therapeutics Inc.$203K0.75%0.01%Not reportedQ3 2024
AUTLAutolus Therapeutics plc$202K0.75%0.44%+5.8%Q4 2023
CELCCelcuity Inc.$195K0.72%0.09%NewQ3 2025
MREOMereo BioPharma Group plc$167K0.62%0.10%Not reportedQ3 2024
JANXJanux Therapeutics, Inc.$129K0.48%0.08%Not reportedQ4 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.